Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 09, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons in the company's Ordinary Shares, specifically relating to the GlaxoSmithKline Employee Trust ("GSK Trust").
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of share transactions rather than a financial performance report.
Material Changes
The filing details specific share movements within the GSK Trust during early August 2006:
- August 7, 2006: The GSK Trust transferred 3,637 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- August 8, 2006: The GSK Trust received 1,534 Ordinary Shares due to the reversal of an incorrect exercise.
- August 8, 2006: The GSK Trust transferred 3,440 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
These transactions were advised to the company on August 8 and August 9, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Investor Verification Checklist
- Verify the total number of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 (7,077 shares total across two dates).
- Confirm the net impact of the share reversal (1,534 shares) on the trust's holdings.
- Review the specific terms of the SmithKline Beecham Employee Share Option Plan 1991 to understand the vesting or exercise conditions for the recipients.
- Check subsequent filings for any further changes in director interests related to the GSK Trust.